Biotech

Latest Articles

Former Seagen chief executive officer unveils brand-new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer last year for an ...

Ironwood creates further bid for $1B GI drug with brand-new subgroup data

.On the heels of a stage 3 gain that failed to excite entrepreneurs, Ironwood Pharmaceuticals is bac...

Novartis inks $150M deal for autoimmune molecular adhesive

.Don't cease Monte Rosa Rehabs right now. The Boston-based biotech is enjoying after authorizing a h...

Jade carves out exec group with Chinook veterinarians-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shooting...

Septerna goes social with upsized offering of $288M

.Commemorating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer rang the openin...

AbbVie makes Richter wealthier, spending $25M to create invention pact

.AbbVie has actually returned to the resource of its antipsychotic powerhouse Vraylar looking for an...

GenSight gets in last full weeks of cash path as income stream edges out of reach

.GenSight Biologics is actually full weeks away from losing cash. Once again. The biotech only has s...

AZ licenses disposed of unusual health condition medication to Monopar Therapies

.Monopar Therapeutics is actually recuperating a drug coming from the scrap heap of AstraZeneca's un...

Arcus' brand-new HIF-2a information in kidney cancer cells mention prospective edge over Merck's Welireg, professionals say

.With brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of experts...

Roche bets as much as $1B to broaden Dyno genetics therapy shipment contract

.After forming a gene therapy alliance along with Dyno Rehabs in 2020, Roche is back for even more.I...

Lundbeck slashes worth of $250M Abide purchase after discomfort problem

.Lundbeck is reducing the book market value of its $250 thousand Abide Therapeutics acquistion in re...

Real- Globe Data Fulfills Clinical Trial Design: Maximizing Protocols as well as Website Variety

.The integration of real-world data (RWD) right into process expediency and also web site collection...

Where are they now? Catching up with previous Brutal 15 honorees

.At this year's Strong Biotech Top in Boston ma, our team caught up with leaders in the biotech indu...

Merck buys preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is taking down $30 million in advance to acquire Yale spinout Modifi Biosciences, a ...

Radiopharma Alpha-9 raises $175M series C to money scientific push

.Alpha-9 Oncology has actually raised a $175 million collection C cycle to money its clinical-stage ...

Ocuphire to improve right into genetics treatment biotech by means of Opus purchase

.Eye medication creator Ocuphire Pharma is getting genetics treatment creator Piece Genes in an all-...

Roche culls hack candidate, pivots KRAS system in Q3 upgrade

.Roche's constant cough program has sputtered to a standstill. The drugmaker, which axed the plan af...

Merck- Gilead long-acting dental combination restrains HIV for 48 weeks

.Gilead Sciences and Merck &amp Co. have actually assisted their once-weekly HIV mixture treatment p...

Lykos takes FDA watch that MDMA approval depends on fresh trial

.Lykos Therapeutics may possess dropped three-quarters of its staff following the FDA's denial of it...

Septerna intends $158M IPO to finance readouts for GPCR pipe

.Septerna may be actually as yet to reveal "any kind of relevant medical records," but the biotech c...